PDB Short entry for 3ET1 HEADER TRANSCRIPTION/TRANSFERASE 06-OCT-08 3ET1 TITLE STRUCTURE OF PPARALPHA WITH 3-[5-METHOXY-1-(4-METHOXY- TITLE 2 BENZENESULFONYL)-1H-INDOL-3-YL]-PROPIONIC ACID COMPND MOL_ID: 1; COMPND 2 MOLECULE: PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR ALPHA; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: LIGAND BINDING DOMAIN; COMPND 5 SYNONYM: PPAR-ALPHA, NUCLEAR RECEPTOR SUBFAMILY 1 GROUP C MEMBER 1; COMPND 6 ENGINEERED: YES; COMPND 7 MOL_ID: 2; COMPND 8 MOLECULE: STEROID RECEPTOR COACTIVATOR 1; COMPND 9 CHAIN: P, Q; COMPND 10 FRAGMENT: RESIDUES 681-696; COMPND 11 SYNONYM: NCOA-1, NUCLEAR RECEPTOR COACTIVATOR 1, SRC-1, RIP160, COMPND 12 PROTEIN HIN-2, RENAL CARCINOMA ANTIGEN NY-REN-52; COMPND 13 EC: 2.3.1.48; COMPND 14 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: PPARA, NR1C1, PPAR; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3)RIL; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET-28; SOURCE 11 MOL_ID: 2; SOURCE 12 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 13 ORGANISM_COMMON: HUMAN; SOURCE 14 ORGANISM_TAXID: 9606; SOURCE 15 GENE: NCOA1, SRC1; SOURCE 16 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 17 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 18 EXPRESSION_SYSTEM_STRAIN: BL21(DE3)RIL; SOURCE 19 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 20 EXPRESSION_SYSTEM_PLASMID: PET-28 KEYWDS PPAR, PPARA, PPARALPHA, DRUG DISCOVERY, DIABETES, ADIPONECTIN, KEYWDS 2 METABOLIC DISEASE, FRAGMENT-BASED DRUG DISCOVERY, SCAFFOLD-BASED KEYWDS 3 DRUG DISCOVERY, ACTIVATOR, DNA-BINDING, METAL-BINDING, NUCLEUS, KEYWDS 4 POLYMORPHISM, RECEPTOR, TRANSCRIPTION, TRANSCRIPTION REGULATION, KEYWDS 5 ZINC, ZINC-FINGER, ACYLTRANSFERASE, ALTERNATIVE SPLICING, KEYWDS 6 CHROMOSOMAL REARRANGEMENT, PHOSPHOPROTEIN, PROTO-ONCOGENE, KEYWDS 7 TRANSFERASE, UBL CONJUGATION, TRANSCRIPTION-TRANSFERASE COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR K.Y.J.ZHANG,W.WANG REVDAT 2 06-SEP-23 3ET1 1 REMARK SEQADV REVDAT 1 17-FEB-09 3ET1 0 JRNL AUTH D.R.ARTIS,J.J.LIN,C.ZHANG,W.WANG,U.MEHRA,M.PERREAULT,D.ERBE, JRNL AUTH 2 H.I.KRUPKA,B.P.ENGLAND,J.ARNOLD,A.N.PLOTNIKOV,A.MARIMUTHU, JRNL AUTH 3 H.NGUYEN,S.WILL,M.SIGNAEVSKY,J.KRAL,J.CANTWELL, JRNL AUTH 4 C.SETTACHATGULL,D.S.YAN,D.FONG,A.OH,S.SHI,P.WOMACK,B.POWELL, JRNL AUTH 5 G.HABETS,B.L.WEST,K.Y.ZHANG,M.V.MILBURN,G.P.VLASUK, JRNL AUTH 6 K.P.HIRTH,K.NOLOP,G.BOLLAG,P.N.IBRAHIM,J.F.TOBIN JRNL TITL SCAFFOLD-BASED DISCOVERY OF INDEGLITAZAR, A PPAR PAN-ACTIVE JRNL TITL 2 ANTI-DIABETIC AGENT JRNL REF PROC.NATL.ACAD.SCI.USA V. 106 262 2009 JRNL REFN ISSN 0027-8424 JRNL PMID 19116277 JRNL DOI 10.1073/PNAS.0811325106 REMARK 2 REMARK 2 RESOLUTION. 2.50 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (PHENIX.REFINE) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.50 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 44.80 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.350 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.7 REMARK 3 NUMBER OF REFLECTIONS : 26918 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.198 REMARK 3 R VALUE (WORKING SET) : 0.195 REMARK 3 FREE R VALUE : 0.258 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.020 REMARK 3 FREE R VALUE TEST SET COUNT : 1352 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 44.8047 - 5.3835 0.99 2725 132 0.1830 0.2475 REMARK 3 2 5.3835 - 4.2741 1.00 2591 140 0.1559 0.2065 REMARK 3 3 4.2741 - 3.7342 1.00 2548 159 0.1669 0.2094 REMARK 3 4 3.7342 - 3.3929 1.00 2567 133 0.1949 0.2951 REMARK 3 5 3.3929 - 3.1498 1.00 2530 153 0.2140 0.2816 REMARK 3 6 3.1498 - 2.9641 1.00 2559 110 0.2305 0.3122 REMARK 3 7 2.9641 - 2.8157 1.00 2492 152 0.2154 0.2963 REMARK 3 8 2.8157 - 2.6931 0.99 2501 136 0.2192 0.3142 REMARK 3 9 2.6931 - 2.5895 0.99 2556 115 0.2392 0.2948 REMARK 3 10 2.5895 - 2.5000 0.99 2497 122 0.2627 0.3597 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : 0.34 REMARK 3 B_SOL : 68.83 REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.410 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 26.670 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -15.91500 REMARK 3 B22 (A**2) : 5.85650 REMARK 3 B33 (A**2) : 10.05860 REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.000 4634 REMARK 3 ANGLE : 0.950 6251 REMARK 3 CHIRALITY : 0.060 712 REMARK 3 PLANARITY : 0.000 794 REMARK 3 DIHEDRAL : 17.630 1757 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 2 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: CHAIN A REMARK 3 ORIGIN FOR THE GROUP (A): 3.3401 21.1978 29.6397 REMARK 3 T TENSOR REMARK 3 T11: 0.5800 T22: 0.4034 REMARK 3 T33: 0.4585 T12: 0.0310 REMARK 3 T13: 0.1039 T23: 0.0475 REMARK 3 L TENSOR REMARK 3 L11: 3.0894 L22: 1.7002 REMARK 3 L33: 1.9190 L12: 0.7360 REMARK 3 L13: -1.0927 L23: 0.0392 REMARK 3 S TENSOR REMARK 3 S11: 0.1554 S12: -0.1770 S13: 0.2665 REMARK 3 S21: -0.0004 S22: 0.1312 S23: 0.1447 REMARK 3 S31: -0.2622 S32: -0.1234 S33: -0.0000 REMARK 3 TLS GROUP : 2 REMARK 3 SELECTION: CHAIN B REMARK 3 ORIGIN FOR THE GROUP (A): 0.1752 28.6138 -4.7973 REMARK 3 T TENSOR REMARK 3 T11: 0.3949 T22: 0.4994 REMARK 3 T33: 0.4163 T12: -0.0124 REMARK 3 T13: 0.0078 T23: -0.0632 REMARK 3 L TENSOR REMARK 3 L11: 2.3242 L22: 2.1208 REMARK 3 L33: 1.9507 L12: 0.5954 REMARK 3 L13: 1.1125 L23: 0.7946 REMARK 3 S TENSOR REMARK 3 S11: 0.1096 S12: -0.0778 S13: -0.0544 REMARK 3 S21: -0.0998 S22: 0.0328 S23: -0.0751 REMARK 3 S31: -0.0120 S32: 0.1573 S33: 0.0002 REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 3ET1 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 08-OCT-08. REMARK 100 THE DEPOSITION ID IS D_1000049730. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 14-JUL-05 REMARK 200 TEMPERATURE (KELVIN) : 93 REMARK 200 PH : 8.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ALS REMARK 200 BEAMLINE : 8.3.1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.1 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 210 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 26993 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.500 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 200 DATA REDUNDANCY : 4.800 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.04500 REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.50 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.57 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.5 REMARK 200 DATA REDUNDANCY IN SHELL : 4.90 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : 0.31900 REMARK 200 <I/SIGMA(I)> FOR SHELL : 1.300 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: CCP4 REMARK 200 STARTING MODEL: PDB ENTRY 1KKQ REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 54.88 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.73 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: THE PURIFIED PPARA LBD PROTEIN WAS REMARK 280 DILUTED TO 10 MG/ML AND 1MM OF INDEGLITAZAR AND 2X MOLAR EXCESS REMARK 280 OF SRC-1 PEPTIDE WERE ADDED PRIOR TO CRYSTALLIZATION BY MIXING REMARK 280 EQUAL VOLUMES OF PROTEIN/COMPOUND SAMPLE WITH RESERVOIR SOLUTION REMARK 280 CONTAINING 16% PEG 8000, 0.1 M TRIS BUFFER AT PH 8.0, 0.02 M REMARK 280 LITHIUM SULFATE, AND 5% GLYCEROL, VAPOR DIFFUSION, SITTING DROP, REMARK 280 TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 41.93450 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 50.55750 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 44.79750 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 50.55750 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 41.93450 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 44.79750 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1390 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 13850 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -10.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, P REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1350 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 13970 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -9.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: B, Q REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 178 REMARK 465 GLY A 179 REMARK 465 SER A 180 REMARK 465 SER A 181 REMARK 465 HIS A 182 REMARK 465 HIS A 183 REMARK 465 HIS A 184 REMARK 465 HIS A 185 REMARK 465 HIS A 186 REMARK 465 HIS A 187 REMARK 465 SER A 188 REMARK 465 SER A 189 REMARK 465 GLY A 190 REMARK 465 LEU A 191 REMARK 465 VAL A 192 REMARK 465 PRO A 193 REMARK 465 ARG A 194 REMARK 465 GLY A 195 REMARK 465 SER A 196 REMARK 465 HIS A 197 REMARK 465 MET A 198 REMARK 465 LYS A 257 REMARK 465 LEU A 258 REMARK 465 VAL A 259 REMARK 465 ALA A 260 REMARK 465 ASN A 261 REMARK 465 GLY A 262 REMARK 465 ILE A 263 REMARK 465 MET B 178 REMARK 465 GLY B 179 REMARK 465 SER B 180 REMARK 465 SER B 181 REMARK 465 HIS B 182 REMARK 465 HIS B 183 REMARK 465 HIS B 184 REMARK 465 HIS B 185 REMARK 465 HIS B 186 REMARK 465 HIS B 187 REMARK 465 SER B 188 REMARK 465 SER B 189 REMARK 465 GLY B 190 REMARK 465 LEU B 191 REMARK 465 VAL B 192 REMARK 465 PRO B 193 REMARK 465 ARG B 194 REMARK 465 GLY B 195 REMARK 465 SER B 196 REMARK 465 HIS B 197 REMARK 465 MET B 198 REMARK 465 SER P 681 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LEU A 254 -145.09 59.00 REMARK 500 ASN A 265 91.82 68.31 REMARK 500 LYS A 266 -120.23 -126.94 REMARK 500 LEU A 347 177.10 -58.28 REMARK 500 LYS A 349 -87.80 21.06 REMARK 500 LEU A 392 -78.30 -72.45 REMARK 500 THR A 450 42.70 -103.42 REMARK 500 ARG A 465 94.12 -42.98 REMARK 500 ASP A 466 43.10 74.19 REMARK 500 MET A 467 -72.20 -93.38 REMARK 500 SER B 230 -71.49 -75.63 REMARK 500 SER B 234 133.72 82.77 REMARK 500 ILE B 263 99.98 -58.14 REMARK 500 CYS B 384 55.35 -96.53 REMARK 500 ASN B 393 62.61 -102.37 REMARK 500 MET B 467 -74.75 -85.05 REMARK 500 LYS P 688 -76.52 -56.88 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ET1 A 1 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ET1 B 2 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 3ET0 RELATED DB: PDB REMARK 900 STRUCTURE OF PPARGAMMA WITH 3-(5-METHOXY-1H-INDOL-3-YL)-PROPIONIC REMARK 900 ACID REMARK 900 RELATED ID: 3ET2 RELATED DB: PDB REMARK 900 STRUCTURE OF PPARDELTA WITH 3-[5-METHOXY-1-(4-METHOXY- REMARK 900 BENZENESULFONYL)-1H-INDOL-3-YL]-PROPIONIC ACID REMARK 900 RELATED ID: 3ET3 RELATED DB: PDB REMARK 900 STRUCTURE OF PPARGAMMA WITH 3-[5-METHOXY-1-(4-METHOXY- REMARK 900 BENZENESULFONYL)-1H-INDOL-3-YL]-PROPIONIC ACID DBREF 3ET1 A 199 468 UNP Q07869 PPARA_HUMAN 199 468 DBREF 3ET1 B 199 468 UNP Q07869 PPARA_HUMAN 199 468 DBREF 3ET1 P 681 696 UNP Q15788 NCOA1_HUMAN 681 696 DBREF 3ET1 Q 681 696 UNP Q15788 NCOA1_HUMAN 681 696 SEQADV 3ET1 MET A 178 UNP Q07869 EXPRESSION TAG SEQADV 3ET1 GLY A 179 UNP Q07869 EXPRESSION TAG SEQADV 3ET1 SER A 180 UNP Q07869 EXPRESSION TAG SEQADV 3ET1 SER A 181 UNP Q07869 EXPRESSION TAG SEQADV 3ET1 HIS A 182 UNP Q07869 EXPRESSION TAG SEQADV 3ET1 HIS A 183 UNP Q07869 EXPRESSION TAG SEQADV 3ET1 HIS A 184 UNP Q07869 EXPRESSION TAG SEQADV 3ET1 HIS A 185 UNP Q07869 EXPRESSION TAG SEQADV 3ET1 HIS A 186 UNP Q07869 EXPRESSION TAG SEQADV 3ET1 HIS A 187 UNP Q07869 EXPRESSION TAG SEQADV 3ET1 SER A 188 UNP Q07869 EXPRESSION TAG SEQADV 3ET1 SER A 189 UNP Q07869 EXPRESSION TAG SEQADV 3ET1 GLY A 190 UNP Q07869 EXPRESSION TAG SEQADV 3ET1 LEU A 191 UNP Q07869 EXPRESSION TAG SEQADV 3ET1 VAL A 192 UNP Q07869 EXPRESSION TAG SEQADV 3ET1 PRO A 193 UNP Q07869 EXPRESSION TAG SEQADV 3ET1 ARG A 194 UNP Q07869 EXPRESSION TAG SEQADV 3ET1 GLY A 195 UNP Q07869 EXPRESSION TAG SEQADV 3ET1 SER A 196 UNP Q07869 EXPRESSION TAG SEQADV 3ET1 HIS A 197 UNP Q07869 EXPRESSION TAG SEQADV 3ET1 MET A 198 UNP Q07869 EXPRESSION TAG SEQADV 3ET1 MET B 178 UNP Q07869 EXPRESSION TAG SEQADV 3ET1 GLY B 179 UNP Q07869 EXPRESSION TAG SEQADV 3ET1 SER B 180 UNP Q07869 EXPRESSION TAG SEQADV 3ET1 SER B 181 UNP Q07869 EXPRESSION TAG SEQADV 3ET1 HIS B 182 UNP Q07869 EXPRESSION TAG SEQADV 3ET1 HIS B 183 UNP Q07869 EXPRESSION TAG SEQADV 3ET1 HIS B 184 UNP Q07869 EXPRESSION TAG SEQADV 3ET1 HIS B 185 UNP Q07869 EXPRESSION TAG SEQADV 3ET1 HIS B 186 UNP Q07869 EXPRESSION TAG SEQADV 3ET1 HIS B 187 UNP Q07869 EXPRESSION TAG SEQADV 3ET1 SER B 188 UNP Q07869 EXPRESSION TAG SEQADV 3ET1 SER B 189 UNP Q07869 EXPRESSION TAG SEQADV 3ET1 GLY B 190 UNP Q07869 EXPRESSION TAG SEQADV 3ET1 LEU B 191 UNP Q07869 EXPRESSION TAG SEQADV 3ET1 VAL B 192 UNP Q07869 EXPRESSION TAG SEQADV 3ET1 PRO B 193 UNP Q07869 EXPRESSION TAG SEQADV 3ET1 ARG B 194 UNP Q07869 EXPRESSION TAG SEQADV 3ET1 GLY B 195 UNP Q07869 EXPRESSION TAG SEQADV 3ET1 SER B 196 UNP Q07869 EXPRESSION TAG SEQADV 3ET1 HIS B 197 UNP Q07869 EXPRESSION TAG SEQADV 3ET1 MET B 198 UNP Q07869 EXPRESSION TAG SEQRES 1 A 291 MET GLY SER SER HIS HIS HIS HIS HIS HIS SER SER GLY SEQRES 2 A 291 LEU VAL PRO ARG GLY SER HIS MET GLU THR ALA ASP LEU SEQRES 3 A 291 LYS SER LEU ALA LYS ARG ILE TYR GLU ALA TYR LEU LYS SEQRES 4 A 291 ASN PHE ASN MET ASN LYS VAL LYS ALA ARG VAL ILE LEU SEQRES 5 A 291 SER GLY LYS ALA SER ASN ASN PRO PRO PHE VAL ILE HIS SEQRES 6 A 291 ASP MET GLU THR LEU CYS MET ALA GLU LYS THR LEU VAL SEQRES 7 A 291 ALA LYS LEU VAL ALA ASN GLY ILE GLN ASN LYS GLU ALA SEQRES 8 A 291 GLU VAL ARG ILE PHE HIS CYS CYS GLN CYS THR SER VAL SEQRES 9 A 291 GLU THR VAL THR GLU LEU THR GLU PHE ALA LYS ALA ILE SEQRES 10 A 291 PRO GLY PHE ALA ASN LEU ASP LEU ASN ASP GLN VAL THR SEQRES 11 A 291 LEU LEU LYS TYR GLY VAL TYR GLU ALA ILE PHE ALA MET SEQRES 12 A 291 LEU SER SER VAL MET ASN LYS ASP GLY MET LEU VAL ALA SEQRES 13 A 291 TYR GLY ASN GLY PHE ILE THR ARG GLU PHE LEU LYS SER SEQRES 14 A 291 LEU ARG LYS PRO PHE CYS ASP ILE MET GLU PRO LYS PHE SEQRES 15 A 291 ASP PHE ALA MET LYS PHE ASN ALA LEU GLU LEU ASP ASP SEQRES 16 A 291 SER ASP ILE SER LEU PHE VAL ALA ALA ILE ILE CYS CYS SEQRES 17 A 291 GLY ASP ARG PRO GLY LEU LEU ASN VAL GLY HIS ILE GLU SEQRES 18 A 291 LYS MET GLN GLU GLY ILE VAL HIS VAL LEU ARG LEU HIS SEQRES 19 A 291 LEU GLN SER ASN HIS PRO ASP ASP ILE PHE LEU PHE PRO SEQRES 20 A 291 LYS LEU LEU GLN LYS MET ALA ASP LEU ARG GLN LEU VAL SEQRES 21 A 291 THR GLU HIS ALA GLN LEU VAL GLN ILE ILE LYS LYS THR SEQRES 22 A 291 GLU SER ASP ALA ALA LEU HIS PRO LEU LEU GLN GLU ILE SEQRES 23 A 291 TYR ARG ASP MET TYR SEQRES 1 B 291 MET GLY SER SER HIS HIS HIS HIS HIS HIS SER SER GLY SEQRES 2 B 291 LEU VAL PRO ARG GLY SER HIS MET GLU THR ALA ASP LEU SEQRES 3 B 291 LYS SER LEU ALA LYS ARG ILE TYR GLU ALA TYR LEU LYS SEQRES 4 B 291 ASN PHE ASN MET ASN LYS VAL LYS ALA ARG VAL ILE LEU SEQRES 5 B 291 SER GLY LYS ALA SER ASN ASN PRO PRO PHE VAL ILE HIS SEQRES 6 B 291 ASP MET GLU THR LEU CYS MET ALA GLU LYS THR LEU VAL SEQRES 7 B 291 ALA LYS LEU VAL ALA ASN GLY ILE GLN ASN LYS GLU ALA SEQRES 8 B 291 GLU VAL ARG ILE PHE HIS CYS CYS GLN CYS THR SER VAL SEQRES 9 B 291 GLU THR VAL THR GLU LEU THR GLU PHE ALA LYS ALA ILE SEQRES 10 B 291 PRO GLY PHE ALA ASN LEU ASP LEU ASN ASP GLN VAL THR SEQRES 11 B 291 LEU LEU LYS TYR GLY VAL TYR GLU ALA ILE PHE ALA MET SEQRES 12 B 291 LEU SER SER VAL MET ASN LYS ASP GLY MET LEU VAL ALA SEQRES 13 B 291 TYR GLY ASN GLY PHE ILE THR ARG GLU PHE LEU LYS SER SEQRES 14 B 291 LEU ARG LYS PRO PHE CYS ASP ILE MET GLU PRO LYS PHE SEQRES 15 B 291 ASP PHE ALA MET LYS PHE ASN ALA LEU GLU LEU ASP ASP SEQRES 16 B 291 SER ASP ILE SER LEU PHE VAL ALA ALA ILE ILE CYS CYS SEQRES 17 B 291 GLY ASP ARG PRO GLY LEU LEU ASN VAL GLY HIS ILE GLU SEQRES 18 B 291 LYS MET GLN GLU GLY ILE VAL HIS VAL LEU ARG LEU HIS SEQRES 19 B 291 LEU GLN SER ASN HIS PRO ASP ASP ILE PHE LEU PHE PRO SEQRES 20 B 291 LYS LEU LEU GLN LYS MET ALA ASP LEU ARG GLN LEU VAL SEQRES 21 B 291 THR GLU HIS ALA GLN LEU VAL GLN ILE ILE LYS LYS THR SEQRES 22 B 291 GLU SER ASP ALA ALA LEU HIS PRO LEU LEU GLN GLU ILE SEQRES 23 B 291 TYR ARG ASP MET TYR SEQRES 1 P 16 SER SER LEU THR GLU ARG HIS LYS ILE LEU HIS ARG LEU SEQRES 2 P 16 LEU GLN GLU SEQRES 1 Q 16 SER SER LEU THR GLU ARG HIS LYS ILE LEU HIS ARG LEU SEQRES 2 Q 16 LEU GLN GLU HET ET1 A 1 27 HET ET1 B 2 27 HETNAM ET1 3-{5-METHOXY-1-[(4-METHOXYPHENYL)SULFONYL]-1H-INDOL-3- HETNAM 2 ET1 YL}PROPANOIC ACID FORMUL 5 ET1 2(C19 H19 N O6 S) FORMUL 7 HOH *93(H2 O) HELIX 1 1 SER A 205 PHE A 218 1 14 HELIX 2 2 ASN A 221 SER A 230 1 10 HELIX 3 3 ASP A 243 LYS A 252 1 10 HELIX 4 4 GLU A 267 ALA A 293 1 27 HELIX 5 5 ASP A 301 SER A 322 1 22 HELIX 6 6 ALA A 333 GLY A 335 5 3 HELIX 7 7 ARG A 341 LEU A 347 1 7 HELIX 8 8 PRO A 350 ILE A 354 5 5 HELIX 9 9 MET A 355 ALA A 367 1 13 HELIX 10 10 ASP A 371 CYS A 384 1 14 HELIX 11 11 ASN A 393 HIS A 416 1 24 HELIX 12 12 PHE A 421 THR A 450 1 30 HELIX 13 13 HIS A 457 ARG A 465 1 9 HELIX 14 14 ALA B 201 PHE B 218 1 18 HELIX 15 15 ASN B 221 GLY B 231 1 11 HELIX 16 16 ASP B 243 ALA B 260 1 18 HELIX 17 17 GLU B 267 ALA B 293 1 27 HELIX 18 18 ASP B 301 SER B 322 1 22 HELIX 19 19 ALA B 333 GLY B 335 5 3 HELIX 20 20 ARG B 341 LEU B 347 1 7 HELIX 21 21 PRO B 350 ILE B 354 5 5 HELIX 22 22 MET B 355 ALA B 367 1 13 HELIX 23 23 ASP B 371 CYS B 384 1 14 HELIX 24 24 ASN B 393 HIS B 416 1 24 HELIX 25 25 PHE B 421 GLU B 451 1 31 HELIX 26 26 HIS B 457 ARG B 465 1 9 HELIX 27 27 SER P 682 HIS P 687 1 6 HELIX 28 28 HIS P 687 GLN P 695 1 9 HELIX 29 29 SER Q 682 HIS Q 687 1 6 HELIX 30 30 HIS Q 687 GLU Q 696 1 10 SHEET 1 A 4 PHE A 239 ILE A 241 0 SHEET 2 A 4 GLY A 337 THR A 340 1 O PHE A 338 N ILE A 241 SHEET 3 A 4 GLY A 329 VAL A 332 -1 N VAL A 332 O GLY A 337 SHEET 4 A 4 MET A 325 ASN A 326 -1 N ASN A 326 O GLY A 329 SHEET 1 B 4 PHE B 239 ILE B 241 0 SHEET 2 B 4 GLY B 337 THR B 340 1 O PHE B 338 N ILE B 241 SHEET 3 B 4 GLY B 329 VAL B 332 -1 N MET B 330 O ILE B 339 SHEET 4 B 4 MET B 325 ASN B 326 -1 N ASN B 326 O GLY B 329 SITE 1 AC1 12 HOH A 15 ILE A 272 PHE A 273 CYS A 276 SITE 2 AC1 12 GLN A 277 THR A 279 SER A 280 TYR A 314 SITE 3 AC1 12 PHE A 318 ILE A 354 MET A 355 TYR A 464 SITE 1 AC2 11 ILE B 272 PHE B 273 CYS B 276 THR B 279 SITE 2 AC2 11 SER B 280 TYR B 314 PHE B 318 ILE B 354 SITE 3 AC2 11 MET B 355 HIS B 440 TYR B 464 CRYST1 83.869 89.595 101.115 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.011923 0.000000 0.000000 0.00000 SCALE2 0.000000 0.011161 0.000000 0.00000 SCALE3 0.000000 0.000000 0.009890 0.00000